These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25790004)

  • 1. Clotting factor XIII and desmopressin improve hemostasis in uncontrolled bleeding.
    Carreiro PR; Rezende-Neto JB; Lisboa Tde A; Ribeiro DD; Camargos ER; Andrade MV; Rizoli SB; Melo JR
    Acta Cir Bras; 2015 Mar; 30(3):170-7. PubMed ID: 25790004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permissive hypotension and desmopressin enhance clot formation.
    Rezende-Neto JB; Rizoli SB; Andrade MV; Ribeiro DD; Lisboa TA; Camargos ER; Martins P; Cunha-Melo JR
    J Trauma; 2010 Jan; 68(1):42-50; discussion 50-1. PubMed ID: 20065756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose Factor XIII administration induces effective hemostasis for trauma-associated coagulopathy (TAC) both in vitro and in rat hemorrhagic shock in vivo models.
    Nagashima F; Inoue S; Koami H; Miike T; Sakamoto Y; Kai K
    J Trauma Acute Care Surg; 2018 Sep; 85(3):588-597. PubMed ID: 29851904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of suture hole bleeding using fibrin sealant: benefits of factor XIII.
    Dickneite G; Metzner H; Nicolay U
    J Surg Res; 2000 Oct; 93(2):201-5. PubMed ID: 11027461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of factor XIII as a component of fibrin sealants.
    Dickneite G; Metzner HJ; Kroez M; Hein B; Nicolay U
    J Surg Res; 2002 Oct; 107(2):186-95. PubMed ID: 12429174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization and Effectiveness of Desmopressin Acetate After Cardiac Surgery Supplemented With Point-of-Care Hemostatic Testing: A Propensity-Score-Matched Analysis.
    Orlov D; McCluskey SA; Callum J; Rao V; Moreno J; Karkouti K
    J Cardiothorac Vasc Anesth; 2017 Jun; 31(3):883-895. PubMed ID: 28169116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desmopressin: a nontransfusional hemostatic agent.
    Mannucci PM
    Annu Rev Med; 1990; 41():55-64. PubMed ID: 2184748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmopressin (dDAVP): a powerful general hemostatic agent?
    Drouet L; Scrobohaci ML; Boudaoud S; Vilain G
    Nouv Rev Fr Hematol (1978); 1989; 31(2):163-5. PubMed ID: 2528120
    [No Abstract]   [Full Text] [Related]  

  • 9. PFA-100 test in the detection of platelet dysfunction and monitoring DDAVP in a patient with liver cirrhosis undergoing inguinal hernia repair.
    Vucelić D; Golubović M; Bjelović M
    Srp Arh Celok Lek; 2012; 140(11-12):782-5. PubMed ID: 23350257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of desmopressin on hemostasis in patients with liver cirrhosis.
    Agnelli G; Parise P; Levi M; Cosmi B; Nenci GG
    Haemostasis; 1995; 25(5):241-7. PubMed ID: 7489963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.
    Hanebutt FL; Rolf N; Loesel A; Kuhlisch E; Siegert G; Knoefler R
    Haemophilia; 2008 May; 14(3):524-30. PubMed ID: 18284449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders.
    Leissinger C; Carcao M; Gill JC; Journeycake J; Singleton T; Valentino L
    Haemophilia; 2014 Mar; 20(2):158-67. PubMed ID: 23937614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic and hemodynamic effects of vasopressin analogue DDAVP in patients with cirrhosis.
    López P; Otaso JC; Alvarez D; Rojter S; Podestá A; Albornoz L; Terg R; Romero G; Mastai R
    Acta Gastroenterol Latinoam; 1997; 27(2):59-62. PubMed ID: 9339235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic and therapeutic measures in congenital blood coagulation disorders].
    Eggert JH
    Dtsch Zahnarztl Z; 1982 Nov; 37(11):877-84. PubMed ID: 6816566
    [No Abstract]   [Full Text] [Related]  

  • 15. DDAVP reduces bleeding during continued hirudin administration in the rabbit.
    Bove CM; Casey B; Marder VJ
    Thromb Haemost; 1996 Mar; 75(3):471-5. PubMed ID: 8701410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDAVP therapy controls bleeding in Ehlers-Danlos syndrome.
    Stine KC; Becton DL
    J Pediatr Hematol Oncol; 1997; 19(2):156-8. PubMed ID: 9149748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery.
    Weber CF; Dietrich W; Spannagl M; Hofstetter C; Jámbor C
    Anesth Analg; 2010 Mar; 110(3):702-7. PubMed ID: 20042444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic response to subcutaneous and intranasal therapy with desmopressin in a large Amish kindred with Type 2M von Willebrand disease.
    Sharthkumar A; Greist A; Di Paola J; Winay J; Roberson C; Heiman M; Herbert S; Parameswaran R; Shapiro A
    Haemophilia; 2008 May; 14(3):539-48. PubMed ID: 18312368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery.
    Hackmann T; Gascoyne RD; Naiman SC; Growe GH; Burchill LD; Jamieson WR; Sheps SB; Schechter MT; Townsend GE
    N Engl J Med; 1989 Nov; 321(21):1437-43. PubMed ID: 2682243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical application of new synthetic vasopressin 1-deamino-8-D-arginine vasopressin (DDAVP): hemostatic control of von Willebrand's disease (author's transl)].
    Kobayashi I; Takahashi H; Sanada M; Takahashi K; Hattori A; Ito M; Sakuragawa N; Shibata A; Shinada S; Tsukada T
    Rinsho Ketsueki; 1979 Apr; 20(4):364-71. PubMed ID: 312954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.